Autism spectrum disorders (ASD) reflect a critical gap in medical care, often involving challenges in social communication, with limited treatments available for core symptoms. A key barrier to ...

In another important milestone, PeriVision has signed a clinical trial agreement with Genentech, Roche's US business unit. The aim is to evaluate the potential use of the VisionOne platform in ...

Mabylon AG is a Schlieren-based biotechnology company at the forefront of human-derived antibody research, with a primary focus on allergies, neurological and inflammatory disorders. The company has ...

Unlike traditional aligners, which often cause oral hygiene problems such as bacteria build-up, bad breath (halitosis) or cavities, Actival incorporates CSEM's patented 3D-printed microchannel ...

Pelt8 offers user-friendly tools to help businesses comply with various reporting standards. In an effort to further enhance to enhance sustainability reporting for companies of all sizes, especially ...

Swisspod is a Swiss-American company leading the development of the hyperloop technology. During Richard Branson's private ...

Since 2016, Synpl Chem has been developing automated laboratory equipment for chemistry research, today serving customers worldwide including Novartis, AstraZeneca, Lilly and Bayer. The ETH spinoff ...

Swissnex acts as a launchpad for Swiss innovators and startups looking to enter the world's leading innovation and technology hubs. Its equity-free programs are tailored to the needs of entrepreneurs ...

Switzerland has come out on top in three new studies. Both the World Intellectual Property Organisation (WIPO) and the consulting firm Roland Berger have crowned Switzerland the world champion of ...

Programs organized by global organizations including the United Nations, Bosch and Swiss Re have acknowledged the achievements of a Swiss startups, awarding them cash prizes and support to boost their ...

Summa Equity, a Stockholm-based private equity firm has acquired NetGuardians, a Swiss-based pioneer in AI-driven fraud prevention and anti-money laundering solutions. This opens an opportunity for a ...

This funding boost will help Altamira progress their innovative pipeline while also supporting their ongoing divestment of legacy assets in allergology, viral infections, and inner ear disorders.